Paige Announces Expansion of Scientific Advisory Board
Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry…
News
Iron Bow Technologies Awarded 2021 Quest Federal Partner of the Year
HERNDON, Va.–(BUSINESS WIRE)–Iron Bow Technologies, an information technology solutions provider to government, commercial, education, and…
PRO Unlimited Named “Market Leader” in Ardent Partners’ 2022 MSP Solution Advisor Report
PRO ranked highly for the universal strength of its Integrated Workforce Management platform comprised of…
Praxis Precision Medicines to Present at BofA Securities 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022
SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular…
SCYNEXIS to Present New Data of Ibrexafungerp for Refractory Vulvovaginal Candidiasis from Ongoing Phase 3 FURI Study at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting
Product theater presentation will be held on May 7 to highlight clinical data and attributes…
Dyve Biosciences to Present at the UBS Global Healthcare Conference
CAMARILLO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
Gracell Biotechnologies to Participate in Three Investor Conferences in May
SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 04, 2022 (GLOBE NEWSWIRE) — Gracell…
TRACON to Report First Quarter 2022 Financial Results and Corporate Update on May 11, 2022
SAN DIEGO, May 04, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage…
Phathom Pharmaceuticals Announces Revenue Interest Financing Agreement for Up to $260 Million in Non-Dilutive Capital
Upfront payment of $100 million, an additional $160 million available upon FDA approval of vonoprazan…
IN8bio to Present at May Investor and Scientific Conferences
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
CRISPR Therapeutics to Present at the 2022 Bank of America Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Rhythm Pharmaceuticals to Present at BofA Securities 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Immutep Presents New and Significant Data from the AIPAC Study
Statistically significant increase in innate and adaptive immune response biomarkers (monocyte and CD8 T cell…
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
NEWTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Aspargo Acquires Bandol® Sildenafil Spray, Currently Marketed In Spain
Immediate revenue and expansion of global footprint Acquisition transforms Aspargo into a revenue producing company…
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 04, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors
LONDON, May 04, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
Initiated EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Described new understanding…